Beau Ventures
BIIB icon

Beau Ventures’s Biogen BIIB Stock Holding History

Beau Ventures’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.6M Hold
100,000
– – 2.13% 8
2026
Q2 		$21.6M Hold
100,000
– – 2.35% 8
2026
Q1 		$18.3M Hold
100,000
– – 2.46% 7
2025
Q4 		$17.6M Buy
+100,000
New +$16.3M 2.19% 7

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Adams Diversified Equity Fund
Adams Diversified Equity Fund Baltimore, Maryland $3.3B AUM 38.12% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Beau Ventures's BIIB Position: Q3 2026 in Review

Beau Ventures held its Biogen (BIIB) position steady in Q3 2026 at 100,000 shares worth $22.6M. The position accounts for 2.13% of the portfolio, ranked #8.

Beau Ventures first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Beau Ventures held 100,000 shares of Biogen worth $22.6M as of Q3 2026.
  • Beau Ventures left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 2.13% of Beau Ventures's portfolio in Q3 2026, its #8 holding.
  • Beau Ventures first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 317 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Beau Ventures's 13F filing for Q3 2026, filed 14 Oct 2026.